Stem Cell Sciences is an international research and development company specialising in the provision of stem cells and stem cell technologies. Its core objective is to develop safe and effective stem cell-based therapies for currently incurable diseases. It conducts business and scientific operations in Edinburgh, Cambridge, Melbourne and Kobe. Stem Cell Sciences is currently planning to open new offices in California.
Since 1994 Stem Cell Sciences has been active in the stem cell research field, principally focused on technologies to grow, differentiate, and purify embryonic and neural stem cells. The Company now has a substantial portfolio of patents and patent applications in both adult and embryonic stem cell fields. These include technologies to permit the generation of highly purified stem cells and their differentiated progeny for use in genetic, pharmacological and toxicological screens. These technologies can be utilised to provide pure populations of appropriate cell types for transplantation therapies.
Stem Cells Sciences takes pride in its long-standing relationships with leading academic centres of excellence in the stem cell field, which help maintain its position at the cutting edge of the stem cell industry. The Precision Group recognises the need for this type of research and sees enormous benefits for the global population.